|
Build Your Online Product Catalogs?
Product Name: |
Florfenicol injection
|
Supply Ability: |
|
Related proudcts |
veterinary, antibiotics, flor, |
Specifications |
100ml |
Price Term: |
FOB CNF CIF |
Port of loading: |
ANY PORT OF CHINA |
Minimum Order |
|
Unit Price: |
$1 |
|
Florfenicol Injection 20%
Composition:
Each ml contains:
Florfenicol ......................................................200mg
Excipients ad.......................................................1ml
Indications:
This product is indicated for preventive and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before preventive treatment. It is additionally indicated for treatment of acute outbreaks of respiratory disease in pigs caused by strains of Actinobacillus pleuropneumoniae and Pasteurella multocida susceptible to florfenicol.
Administration and Dosage:
For subcutaneous or intramuscular injection.
Cattle:
Treatment (IM): 1 ml per 10 kg body weight, twice at a 48-h interval.
Treatment (SC): 2 ml per 10 kg body weight, administered once.
Prevention (SC): 2 ml per 10 kg body weight, administered once.
The injection should only be given in the neck. The dose should not exceed 10 ml per injection site.
Swine: 1 ml per 15 kg body weight (IM), twice at a 48-hour interval.
The injection should only be given in the neck. The dose should not exceed 3 ml per injection site.
Note: This product is not for use in cattle producing milk for human consumption.
Contraindications:
Not for use in cattle producing milk for human consumption.
Not to be used in adult bulls or boars intended for breeding purposes.
Do not administer in cases of previous allergic reactions to florfenicol.
Side Effects:
In cattle, a decrease in food consumption and transient softening of the faeces may occur during the treatment period. The treated animals recover quickly and completely upon termination of treatment. Administration of the product by the intramuscular and subcutaneous routes may cause inflammatory lesions at injection site which persist for 14 days.
In swine, commonly observed adverse effects are transient diarrhoea |
Company: |
Shijiazhuang Joycome Pharmacutical Co.,Ltd
|
Contact: |
Mr. Ethan Han |
Address: |
Industry Park of Yuanshi Shijiazhuang |
Postcode: |
|
Tel: |
+86 199 33138870 |
Fax: |
+86 311 85114670 |
E-mail: |
|
|
|
|